136 related articles for article (PubMed ID: 16287080)
21. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.
Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; Natrajan R; Kelsey A; Rogers S; Campbell C; Pritchard-Jones K; Khan J
Genes Chromosomes Cancer; 2004 Sep; 41(1):65-79. PubMed ID: 15236318
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
[TBL] [Abstract][Full Text] [Related]
23. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
Schaub R; Burger A; Bausch D; Niggli FK; Schäfer BW; Betts DR
Cancer Genet Cytogenet; 2007 Jan; 172(1):61-5. PubMed ID: 17175381
[TBL] [Abstract][Full Text] [Related]
24. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development.
Maschietto M; de Camargo B; Brentani H; Grundy P; Sredni ST; Torres C; Mota LD; Cunha IW; Patrão DF; Costa CM; Soares FA; Brentani RR; Carraro DM
Oncology; 2008; 75(1-2):81-91. PubMed ID: 18784435
[TBL] [Abstract][Full Text] [Related]
26. Regulation of CRABP-II expression by MycN in Wilms tumor.
Gupta A; Kessler P; Rawwas J; Williams BR
Exp Cell Res; 2008 Dec; 314(20):3663-8. PubMed ID: 18955045
[TBL] [Abstract][Full Text] [Related]
27. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor.
Eggert A; Grotzer MA; Ikegaki N; Zhao H; Cnaan A; Brodeur GM; Evans AE
J Clin Oncol; 2001 Feb; 19(3):689-96. PubMed ID: 11157019
[TBL] [Abstract][Full Text] [Related]
28. Classification of malignant pediatric renal tumors by gene expression.
Huang CC; Cutcliffe C; Coffin C; Sorensen PH; Beckwith JB; Perlman EJ;
Pediatr Blood Cancer; 2006 Jun; 46(7):728-38. PubMed ID: 16425275
[TBL] [Abstract][Full Text] [Related]
29. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.
Vujanić GM; Sandstedt B; Harms D; Kelsey A; Leuschner I; de Kraker J;
Med Pediatr Oncol; 2002 Feb; 38(2):79-82. PubMed ID: 11813170
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
31. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
32. Origins of DNA methylation defects in Wilms tumors.
Anvar Z; Acurzio B; Roma J; Cerrato F; Verde G
Cancer Lett; 2019 Aug; 457():119-128. PubMed ID: 31103718
[TBL] [Abstract][Full Text] [Related]
33. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.
Bardeesy N; Beckwith JB; Pelletier J
Cancer Res; 1995 Jan; 55(2):215-9. PubMed ID: 7812946
[TBL] [Abstract][Full Text] [Related]
34. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
[TBL] [Abstract][Full Text] [Related]
36. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group.
Huang CC; Gadd S; Breslow N; Cutcliffe C; Sredni ST; Helenowski IB; Dome JS; Grundy PE; Green DM; Fritsch MK; Perlman EJ
Clin Cancer Res; 2009 Mar; 15(5):1770-8. PubMed ID: 19208794
[TBL] [Abstract][Full Text] [Related]
37. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
38. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
[TBL] [Abstract][Full Text] [Related]
39. Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients.
Wu X; Feng R; Wang X; Guo F; Liu W
J Cancer Res Ther; 2021 Nov; 17(5):1281-1285. PubMed ID: 34850779
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center.
Ellison DA; Parham DM; Bridge J; Beckwith JB
Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
